EA202192114A1 - Ингибиторы аргиназы и способы их применения - Google Patents

Ингибиторы аргиназы и способы их применения

Info

Publication number
EA202192114A1
EA202192114A1 EA202192114A EA202192114A EA202192114A1 EA 202192114 A1 EA202192114 A1 EA 202192114A1 EA 202192114 A EA202192114 A EA 202192114A EA 202192114 A EA202192114 A EA 202192114A EA 202192114 A1 EA202192114 A1 EA 202192114A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
application
arginase inhibitors
formula
arginase
Prior art date
Application number
EA202192114A
Other languages
English (en)
Russian (ru)
Inventor
Скотт Нэйтан Млинэрски
Тайлер Гриб
Самир Каваткар
Морис Реймонд Верскойл Финлей
Иэн Симпсон
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of EA202192114A1 publication Critical patent/EA202192114A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA202192114A 2019-02-08 2020-02-07 Ингибиторы аргиназы и способы их применения EA202192114A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962802765P 2019-02-08 2019-02-08
PCT/IB2020/050982 WO2020161675A1 (en) 2019-02-08 2020-02-07 Arginase inhibitors and methods of use thereof

Publications (1)

Publication Number Publication Date
EA202192114A1 true EA202192114A1 (ru) 2021-12-01

Family

ID=69770954

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192114A EA202192114A1 (ru) 2019-02-08 2020-02-07 Ингибиторы аргиназы и способы их применения

Country Status (32)

Country Link
US (2) US12435097B2 (cg-RX-API-DMAC7.html)
EP (1) EP3921033B1 (cg-RX-API-DMAC7.html)
JP (1) JP7526734B2 (cg-RX-API-DMAC7.html)
KR (1) KR102759971B1 (cg-RX-API-DMAC7.html)
CN (1) CN113395996B (cg-RX-API-DMAC7.html)
AU (1) AU2020218651B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021015581A2 (cg-RX-API-DMAC7.html)
CL (1) CL2021002056A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021011039A2 (cg-RX-API-DMAC7.html)
CR (1) CR20210463A (cg-RX-API-DMAC7.html)
DK (1) DK3921033T3 (cg-RX-API-DMAC7.html)
DO (2) DOP2021000166A (cg-RX-API-DMAC7.html)
EA (1) EA202192114A1 (cg-RX-API-DMAC7.html)
ES (1) ES2960034T3 (cg-RX-API-DMAC7.html)
FI (1) FI3921033T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20231092T1 (cg-RX-API-DMAC7.html)
HU (1) HUE062968T2 (cg-RX-API-DMAC7.html)
IL (1) IL285108B2 (cg-RX-API-DMAC7.html)
LT (1) LT3921033T (cg-RX-API-DMAC7.html)
MA (1) MA56324B1 (cg-RX-API-DMAC7.html)
MX (1) MX2021009499A (cg-RX-API-DMAC7.html)
MY (1) MY206577A (cg-RX-API-DMAC7.html)
PE (1) PE20220280A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021551902A1 (cg-RX-API-DMAC7.html)
PL (1) PL3921033T3 (cg-RX-API-DMAC7.html)
PT (1) PT3921033T (cg-RX-API-DMAC7.html)
RS (1) RS64781B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202108503PA (cg-RX-API-DMAC7.html)
SI (1) SI3921033T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202300337T1 (cg-RX-API-DMAC7.html)
WO (1) WO2020161675A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202105833B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202007739XA (en) * 2018-02-17 2020-09-29 Astrazeneca Ab Arginase inhibitors and methods of use thereof
TW202228720A (zh) 2020-12-22 2022-08-01 波蘭商昂科艾倫迪治療法股份公司 精胺酸酶抑制劑及其使用方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
SE0300907D0 (sv) * 2003-03-31 2003-03-31 Astrazeneca Ab Novel compounds
WO2010085797A2 (en) 2009-01-26 2010-07-29 The Trustees Of University Of Pennsylvania Arginase inhibitors and methods of use
EP2560978B1 (en) * 2010-04-22 2019-01-30 Mars, Incorporated Inhibitors of arginase and their therapeutic applications
EP3034509B1 (en) * 2010-10-26 2020-04-22 Mars, Incorporated Arginase inhibitors as therapeutics
CA2852685C (en) 2011-10-19 2019-02-26 Mars, Incorporated Inhibitors of arginase and their therapeutic application
RU2671976C2 (ru) 2012-12-17 2018-11-08 Пэрион Сайенсиз, Инк. Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
PL410665A1 (pl) * 2014-12-29 2016-07-04 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Inhibitory arginazy oraz ich zastosowania terapeutyczne
AU2016281620B2 (en) * 2015-06-23 2021-07-22 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
WO2017175185A1 (en) * 2016-04-08 2017-10-12 Novartis Ag Heteroaryl butanoic acid derivatives as lta4h inhibitors
WO2018119440A1 (en) * 2016-12-22 2018-06-28 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
CN108794517B (zh) * 2017-04-27 2021-03-30 南京谷睿生物科技有限公司 一种精氨酸酶抑制剂及其制备方法与用途
SG11202007739XA (en) * 2018-02-17 2020-09-29 Astrazeneca Ab Arginase inhibitors and methods of use thereof
US12215116B2 (en) * 2018-03-13 2025-02-04 Merck Sharp & Dohme Llc Arginase inhibitors and methods of use
WO2019205979A1 (zh) * 2018-04-27 2019-10-31 四川科伦博泰生物医药股份有限公司 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途
MA53427B1 (fr) 2018-08-22 2024-06-28 Astrazeneca Ab Inhibiteurs de l'arginase et leurs méthodes d'utilisation

Also Published As

Publication number Publication date
DK3921033T3 (da) 2023-10-16
AU2020218651B2 (en) 2023-01-12
MY206577A (en) 2024-12-24
JP2022521474A (ja) 2022-04-08
KR102759971B1 (ko) 2025-01-23
DOP2021000166A (es) 2021-09-30
HRP20231092T1 (hr) 2023-12-22
IL285108B1 (en) 2024-06-01
IL285108A (en) 2021-09-30
MX2021009499A (es) 2021-09-08
KR20210126044A (ko) 2021-10-19
PL3921033T3 (pl) 2024-01-15
BR112021015581A2 (pt) 2021-10-05
HUE062968T2 (hu) 2023-12-28
CL2021002056A1 (es) 2022-03-04
ZA202105833B (en) 2025-03-26
ES2960034T3 (es) 2024-02-29
PE20220280A1 (es) 2022-02-25
CR20210463A (es) 2021-10-15
IL285108B2 (en) 2024-10-01
WO2020161675A1 (en) 2020-08-13
CN113395996A (zh) 2021-09-14
US20220106335A1 (en) 2022-04-07
RS64781B1 (sr) 2023-11-30
SG11202108503PA (en) 2021-09-29
EP3921033B1 (en) 2023-07-26
JP7526734B2 (ja) 2024-08-01
US12435097B2 (en) 2025-10-07
CA3127755A1 (en) 2020-08-13
PH12021551902A1 (en) 2022-08-01
SMT202300337T1 (it) 2023-11-13
FI3921033T3 (fi) 2023-09-15
CN113395996B (zh) 2024-05-28
EP3921033A1 (en) 2021-12-15
SI3921033T1 (sl) 2023-11-30
LT3921033T (lt) 2023-09-25
CO2021011039A2 (es) 2021-09-09
AU2020218651A1 (en) 2021-09-30
US20250282800A1 (en) 2025-09-11
MA56324B1 (fr) 2023-10-31
DOP2024000181A (es) 2024-10-15
PT3921033T (pt) 2023-10-11

Similar Documents

Publication Publication Date Title
JOP20200197A1 (ar) مثبطات أرجيناز وطرق لاستخدامها
ZA202409114B (en) MODULATORS OF THR-ß AND METHODS OF USE THEREOF
MX2020011501A (es) Compuestos novedosos.
DOP2024000181A (es) Inhibidores de arginasa y métodos de uso de estos
CY1108908T1 (el) Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4
NO20081582L (no) Benzamidforbindelser anvendbare som histon-deacetylaseinhibitorer
EA201290260A1 (ru) Бензимидазол-имидазольные производные
CY1117080T1 (el) Θεραπευτικος παραγοντας για στενωση του σπονδυλικου σωληνα
EA200401612A1 (ru) Противоаллергические средства
CY1123864T1 (el) Νεα παραγωγα αμινο-ιμιδαζοπυριδινης σαν αναστολεις κινασης janus και φαρμακευτικες χρησεις
CA2624621A1 (en) Pyrazine derivatives
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
EA200701780A1 (ru) Противоопухолевое средство
EA202091886A1 (ru) Ингибиторы аргиназы и способы их применения
EA200700871A1 (ru) Способы нейропротекции
CY1112596T1 (el) Νεες ενωσεις και χρηση αυτων
TH2001004359A (th) ตัวยับยั้งอาร์จิเนสและวิธีการใช้สิ่งดังกล่าว
EA201791817A1 (ru) Ингибиторы kv1.3 и их применение в медицине
EA200701798A1 (ru) Производные 3-арил-1,2-бензизоксазола и их применение в качестве лекарств против рака
RU2015151257A (ru) Фармацевтическое применение соединения гексагидродибензо[a, g]хинолизина
TH2101004589A (th) ตัวยับยั้งอาร์จิเนสและวิธีการใช้สิ่งดังกล่าว
RU2021105178A (ru) Новое терапевтическое лечение патологического воспаления
AR114394A1 (es) Inhibidores de arginasa y sus métodos de uso
PL422539A1 (pl) Związki N-arylosulfonyloindolowe do leczenia chorób OUN
NZ784693A (en) Benzopyrazole compounds and analogues thereof